Faculty Research 1990 - 1999

p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.

Document Type


Publication Date



Animal, Blood, Cell Adhesion, Cell Communication, Cell Cycle/physiology, Cell Division, Cell Size, Cell Transformation, Neoplastic, Cells, Cultured, Cyclin D1/analysis, Cyclin-Dependent Kinases/antagonists & inhibitors, Cyclins/genetics/*physiology, Enzyme Inhibitors, Fibroblasts, G1 Phase/*genetics, Mice, Mice, Knockout, Mice, Nude, Microtubule-Associated Proteins, Mutation, Neoplasms, Experimental, Protein-Serine-Threonine Kinases/antagonists & inhibitors, Retinoblastoma Protein, Signal Transduction

First Page


Last Page


JAX Source

J Cell Biol 1998 Apr 20;141(2):503-14


Proliferation in mammalian cells is controlled primarily in the G1-phase of the cell cycle through the action of the G1 cyclin-dependent kinases, CDK4 and CDK2. To explore the mechanism of cellular response to extrinsic factors, specific loss of function mutations were generated in two negative regulators of G1 progression, p21 and pRB. Individually, these mutations were shown to have significant effects in G1 regulation, and when combined, Rb and p21 mutations caused more profound defects in G1. Moreover, cells deficient for pRB and p21 were uniquely capable of anchorage-independent growth. In contrast, combined absence of pRB and p21 function was not sufficient to overcome contact inhibition of growth nor for tumor formation in nude mice. Finally, animals with the genotype Rb+/-;p21(-/-) succumbed to tumors more rapidly than Rb+/- mice, suggesting that in certain contexts mutations in these two cell cycle regulators can cooperate in tumor development.

Please contact the Joan Staats Library for information regarding this document.